Join us.

We’re working to create a just society and preserve a healthy environment for future generations. Donate today to help.

Donate

How to Diss A Book Without Reading It

When you write a book, particularly one that has something to do with matters political, you have to expect criticism. So when I wrote Legally Poisoned: How the Law Puts Us at Risk from Toxicants (Harvard, 2011), I fully expected it to take a shot or two – not just from some of my colleagues in academia, but also from allies of the chemical industry.

In fact, since this book isn’t exactly my first rodeo, I’ve grown accustomed to reviewers who sometimes misstate some of the specifics of what I’ve written or mangle an idea or two. But they’re usually mistakes made in good faith, or at least that’s been my impression.

So it came as a surprise to me to read the review of Legally Poisoned written by Henry Miller, M.S., M.D., of the Hoover Institution and adjunct fellow of the Competitive Enterprise Institute. Miller’s got a long history of working to defend potential hazards from regulation, including formerly as a trustee for the corporate funded American Council on Science and Health, so it’s no surprise he didn’t care for my book. What surprised me was that his review suggests that he didn’t bother to read much of it before attacking it.

Legally Poisoned is based on recent research into the developmental origins of disease, and it addresses risks posed to developing children by human-created chemicals. Some of those chemicals have already caused harm; others appear to pose serious risks. But disturbingly, we know very little about the nature of the toxicity for the vast majority, because we have insufficient research on their toxicity and how dangerous they might or might not be.

That’s the basis of the book. In reviewing it, Miller got a number of things wrong. But one very big thing stands out, because it betrays his bias.

A key point I make in the book – and not just once or twice – is that we do not have toxicology data for many of the chemicals currently in commerce in the United States. This is a disturbing fact, but it’s not a new one. Any honest scientist who has followed the debate over the years knows it. Miller apparently does not. He asserts in his review that “Chemicals are tested” -- which they aren’t. He then tries to portray me as an alarmist for reporting what is widely known. 

I’ll leave the reader to judge whether I’m an alarmist, but on the factual matter of whether all industrial chemicals are required to be tested, he’s just wrong. A chemical substance, not a pesticide, pharmaceutical or new food additive, proposed for manufacture under the Toxic Substances Control Act must only have, “all available data on chemical identity, production volume, by-products, use, environmental release, disposal practices, and human exposures.” No toxicity data is required. It’s an uncomfortable truth, but the vast majority of industrial chemicals enter commerce without any toxicity data, because it is not legally required.

The law says that if a company has toxicity data on a substance, it must submit it. If it does not have it, there is nothing to report. This invites companies not to conduct toxicity tests, although companies probably do some testing that may or may not be reported. For this reason, the great majority of the 80,000 chemicals in commerce lack toxicity data, although some voluntary efforts have sought to improve this.

Leading developmental toxicologists call for premarket toxicity testing of industrial chemicals so children are at lesser risk. National Academy of Sciences committees echo this. Legally Poisoned concurs. Until this occurs our children are essentially serving as haphazard guinea pigs for contaminants.

Another telling point that Miller gets wrong has to do with the “precautionary principle,” the regulatory notion sometimes characterized as “better safe than sorry.” As applied to chemicals, it essentially means that we shouldn’t allow chemicals in commerce if we don’t have data to know whether they are safe or not. Miller says Legally Poisoned advocates an extreme version of the "precautionary principle," which he then criticizes (writes Miller of the principle: “It posits that all new products, technologies or activities should be prohibited or withdrawn from the market or at least smothered by regulation until there is incontrovertible proof of their safety.”) But the book has only three references to the precautionary principle, all in notes directing the reader to an article on DES. The book did not use this phrase nor did it adopt the interpretation Miller attributes to it. Legally Poisoned does argue that present laws for the vast majority of industrial chemicals are reckless toward the public’s health; if avoiding recklessness is precautionary, so be it.

Finally, Dr. Miller notices a factual premise in Legally Poisoned: The Centers for Disease Control has found to date that U.S. citizens are contaminated by many of 212 industrial chemicals for which the CDC has reliable detection protocols. First, he suggests this is of no particular consequence, then he treats it as the main point.

Readers might be interested in its implications that are spelled out in the book. Pregnant women, children developing in utero, and supposedly “pristine” newborns are contaminated with up to 200 industrial chemicals. Some substances may be toxicologically innocent, but many are known carcinogens, reproductive toxicants, neurotoxicants, and immunotoxicants.

Also, contamination of developing children is not innocent. Scientists have found numerous substances that are hazardous to them. Their concentrations need not be high for toxicity; a number have no known safe level; some harm at a few parts per million or billion.

The neurotoxicants lead, mercury, polychlorinated biphenyls (PCBs), some pesticides, arsenic, and toluene can contribute to autism, learning dysfunctions, behavioral problems, and Parkinson’s disease. The developing brain has one chance to develop properly with few or no opportunities to correct toxicity-caused mistakes.

Immunotoxicants, such as bisphenol A (BPA), diethylstilbestrol (DES), lead, Valium, and PCBs, can prevent the immune system from developing the right balance of disease-fighting cells. This can lead to childhood immuno-deficiencies and possibly foreshadow a lifetime of poorly functioning immune responses.

Phthalates, pesticides, and other hormonal mimics can inhibit or damage male reproductive tracts and their sperm, leading researchers write that males are being “feminized.” Synthetic estrogens have obviously harmed women.

Cancers have been triggered by in utero or early life exposures to diethylstilbestrol, DDT, radiation, and trihalomethanes. Scientists trace childhood leukemias to chromosomal translocations that occur in the womb, setting the stage for a second "hit" after birth leading to cancers. Was Dr. Miller unfamiliar with this research? It’s right there in the book.

I don’t know whether Dr. Miller actually read the book, whether he perhaps staffed it out to someone who didn’t do their homework very well, or whether he just perused it looking for things to attack. Whatever the explanation, he does nobody any service by misstating some of the most important points in the book. I’m prepared for criticism, even ill-informed criticism. But it’s another thing altogether to be in wanton disregard of the law, recent science and the book’s text.

Showing 2,829 results

Carl Cranor | July 19, 2011

How to Diss A Book Without Reading It

When you write a book, particularly one that has something to do with matters political, you have to expect criticism. So when I wrote Legally Poisoned: How the Law Puts Us at Risk from Toxicants (Harvard, 2011), I fully expected it to take a shot or two – not just from some of my colleagues […]

Lena Pons | July 18, 2011

Regulatory Plans Show Agencies at Risk of Failing to Finish Numerous Critical Rules During President Obama’s First Term

In April, CPR released a paper that looked at 12 critical rulemaking activities that we urged the Obama administration to finish by June 2012. The new regulatory agendas released by the agencies earlier this month show that instead of moving forward, the agencies are often slowing down.  Contrary to the “tsunami” of regulations that the Chamber […]

Ben Somberg | July 15, 2011

Debunked SBA Regulatory Costs Study Front and Center at House Energy & Commerce Committee Hearing

The House Energy & Commerce sub-committee on Environment and the Economy held a hearing yesterday on “regulatory chaos” (yikes!). One figure seemed popular: $1.75 trillion. That’s how much regulations cost the U.S. economy each year, sub-committee vice-chair Tim Murphy said in his opening statement. Two of the four witnesses made the same claim in their […]

Daniel Rosenberg | July 14, 2011

Through the Looking Glass: Chemical Industry to Star in the Role of Weeping Walrus at House Hearing on EPA’s Assessment of Toxic Chemicals

Editor’s Note: This morning, CPR President Rena Steinzor will testify at a House hearing regarding EPA’s Integrated Risk Information System chemical database (full testimony). This post by NRDC Senior Attorney Daniel Rosenberg, cross-posted from Switchboard, explains the importance of IRIS and how the program is under attack. Thursday morning, the House Science Committee’s Investigation and […]

Rena Steinzor | July 14, 2011

The Big Business Dilemma: What Could Happen When Government Is Gone

The nation’s capital is all but intolerable these days, even for those of us who have lived here for decades and are used to excessive histrionics and gross summer weather. A pall of bad, hot, wet air has settled over the place, and serves as a backdrop to the slow-motion car wreck that is the debt […]

Lena Pons | July 13, 2011

Some Pleasant Surprises in Agency Regulatory Plans

Last week, the Office of Information and Regulatory Affairs (OIRA) of the Office of Management and Budget released the semiannual regulatory agenda. I pointed out that the agenda, which contains the regulatory agencies’ planned actions, was quite late. Although the plans share problems from past years, like simply pushing back the target dates for regulatory actions, there […]

Thomas McGarity | July 13, 2011

President Obama’s Puzzling New Executive Order: Should the Consumer Financial Protection Bureau Really be Spending Its Precious Time and Resources Weakening Existing Regulations?

On Monday, the White House announced that President Obama had signed a new executive order on federal regulation to supplement January’s executive order to executive branch regulatory agencies. The new executive order is aimed at the “independent agencies,” so named because the heads of those agencies do not serve at the pleasure of the president. By statute, […]

Lesley McAllister | July 12, 2011

The End of the Acid Rain Program

Cross-posted from Environmental Law Prof Blog. Do you realize that the Cross-State Air Pollution Rule finalized by the Environmental Protection Agency  last week represents the end of the famed Acid Rain Program? It’s a good thing because the Acid Rain Program had outlived its usefulness by several years and its allowance market had collapsed. Legislated […]

Ben Somberg | July 8, 2011

Member Scholars Pen Letter to OMB on Attacks on EPA’s IRIS Toxics Database

Last month, the American Chemistry Council sent a letter to Jacob Lew, Director of the Office of Managmenet and Budget, calling on OMB to “take greater responsibility in the coordination and review of chemical safety assessments” and to “require EPA to submit all ongoing EPA IRIS assessments to the NAS for independent review.” The letter […]